Phase II study of paclitaxel (P) twice a week as a radiosensitizer, after paclitaxel-carboplatin (C) induction chemotherapy (IC) in stage IIId–IV head and neck carcinoma (HNC)

Saved in:
Bibliographic Details
Published inEuropean journal of cancer (1990) Vol. 35; p. S172
Main Authors Bouillet, T., Morere, J.F., Despreaux, G., Herman, D., Corré, A., Agranat, P., Coulon, M.A., Brunet, A., Brunel, P., Breau, J.L.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.1999
Online AccessGet full text

Cover

More Information
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(99)81076-4